Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis

Joint Bone Spine. 2013 Dec;80(6):670-1. doi: 10.1016/j.jbspin.2013.03.009. Epub 2013 Apr 23.
No abstract available

Keywords: Interstitial lung disease; Pulmonary fibrosis; Rheumatoid arthritis; Tocilizumab.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Emphysema / chemically induced*
  • Pulmonary Emphysema / etiology
  • Pulmonary Fibrosis / chemically induced*
  • Pulmonary Fibrosis / etiology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab